Supply of Lisdexamfetamine 30 MG Capsules (100 Count Bottle)

This contract involves the manufacture and supply of Lisdexamfetamine 30 MG capsules packaged in 100-count bottles. The capsules must comply with FDA regulations and meet all necessary standards for packaging and labeling, specifically designed for automated pharmacy systems. The contract is a subcontract issued by the Department of Defense through DLA Troop Support, reflecting a procurement under the NAICS code 325412, which encompasses pharmaceutical preparation manufacturing. Responses to this subcontract opportunity must be submitted by July 2, 2026. While there is no specified type of set-aside or additional designation, the procurement emphasizes strict adherence to quality and regulatory standards to ensure suitability for military or government-related healthcare applications. The contract’s place of performance and detailed points of contact are not disclosed, but the primary focus remains on delivering compliant pharmaceutical products for use within defense medical operations.